327 related articles for article (PubMed ID: 12583412)
41. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
42. Phyllodes tumor. Fine needle aspiration cytology of eight cases.
Shabb NS
Acta Cytol; 1997; 41(2):321-6. PubMed ID: 9100761
[TBL] [Abstract][Full Text] [Related]
43. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
44. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
45. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
46. [The important morphological parameters used to differentiate benign/malignant phyllodes tumors of the breast].
Küçük Ü; Pala EE; Bayol Ü; Erdoğan IG
Turk Patoloji Derg; 2012; 28(3):245-50. PubMed ID: 23011827
[TBL] [Abstract][Full Text] [Related]
47. Cellular fibroepithelial lesions of the breast: A long term follow up study.
Yasir S; Nassar A; Jimenez RE; Jenkins SM; Hartmann LC; Degnim AC; Frost M; Visscher DW
Ann Diagn Pathol; 2018 Aug; 35():85-91. PubMed ID: 30029048
[TBL] [Abstract][Full Text] [Related]
48. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
49. Differential cytologic features of fibroepithelial lesions of the breast.
Deen SA; McKee GT; Kissin MW
Diagn Cytopathol; 1999 Feb; 20(2):53-6. PubMed ID: 9951596
[TBL] [Abstract][Full Text] [Related]
50. "Growing fibroadenoma": Are there clinical and pathological features predicting a phyllodes tumor on surgical excision?
Nam G; Donegan L; Gorbounov M; Hacking S; Wiggins D; Ward R; Yakirevich E; Wang Y
Ann Diagn Pathol; 2023 Feb; 62():152069. PubMed ID: 36527840
[TBL] [Abstract][Full Text] [Related]
51. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
[TBL] [Abstract][Full Text] [Related]
52. Giant phyllodes tumour of the breast.
Walravens C; De Greef C
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):e9-11. PubMed ID: 18042445
[TBL] [Abstract][Full Text] [Related]
53. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology?
Scolyer RA; McKenzie PR; Achmed D; Lee CS
Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409
[TBL] [Abstract][Full Text] [Related]
54. Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens.
Yasir S; Gamez R; Jenkins S; Visscher DW; Nassar A
Am J Clin Pathol; 2014 Sep; 142(3):362-9. PubMed ID: 25125627
[TBL] [Abstract][Full Text] [Related]
55. Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
Tummidi S; Kothari K; Agnihotri M; Naik L; Sood P
BMC Cancer; 2020 Jul; 20(1):648. PubMed ID: 32660435
[TBL] [Abstract][Full Text] [Related]
56. Quantification of the morphologic features of fibroepithelial tumors of the breast.
McKenna AM; Pintilie M; Youngson B; Done SJ
Arch Pathol Lab Med; 2007 Oct; 131(10):1568-73. PubMed ID: 17922594
[TBL] [Abstract][Full Text] [Related]
57. Connective tissue stromal changes in tumours and tumour-like lesions of the breast.
Pai MR; Pai KN; Rao RV; Naik R; Shankarnarayana ; Baliga P
Indian J Pathol Microbiol; 1999 Jul; 42(3):327-32. PubMed ID: 10862293
[TBL] [Abstract][Full Text] [Related]
58. Comparison of stromal CD10 expression in benign, borderline, and malignant phyllodes tumors among Egyptian female patients.
Ibrahim WS
Indian J Pathol Microbiol; 2011; 54(4):741-4. PubMed ID: 22234101
[TBL] [Abstract][Full Text] [Related]
59. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
60. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
